ANAPTYSBIO, INC 10-Q filing
Filed 2025-11-04 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001370053-25-000089
- Form type
- 10-Q
- CIK
- 0001370053
- Primary document
- https://www.sec.gov/Archives/edgar/data/1370053/000137005325000089/anab-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ANAPTYSBIO, INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $126.4M | - | - |
| Operating Income | $-19.0M | - | - |
| Net Income | $-62.8M | - | - |
| Eps Basic | -2.16 | - | - |
| Eps Diluted | -2.16 | - | - |
| Cash And Equivalents | $109.8M | - | - |
| Total Assets | $353.1M | - | - |
| Shareholders Equity | $-29.4M | - | - |
| Operating Cash Flow | $-78.3M | - | - |
| Capital Expenditures | $86,000 | - | - |